Economic evaluations of childhood influenza vaccination: a critical review
- PMID: 22788257
- DOI: 10.2165/11599130-000000000-00000
Economic evaluations of childhood influenza vaccination: a critical review
Abstract
The potential benefits of influenza vaccination programmes targeted at children have gained increasing attention in recent years. We conducted a literature search of economic evaluations of influenza vaccination in those aged ≤18 years. The search revealed 20 relevant articles, which were reviewed. The studies differed widely in terms of the costs and benefits that were included. The conclusions were generally favourable for vaccination, but often applied a wider perspective (i.e. including productivity losses) than the reference case for economic evaluations used in many countries. Several evaluations estimated outcomes from a single-year epidemiological study, which may limit their validity given the year-to-year variation in influenza transmissibility, virulence, vaccine match and prior immunity. Only one study used a dynamic transmission model able to fully incorporate the indirect herd protection to the wider community. The use of dynamic models offers great scope to capture the population-wide implications of seasonal vaccination efforts, particularly those targeted at children.
Similar articles
-
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Epub 2013 Jan 28. Hum Vaccin Immunother. 2013. PMID: 23357859 Free PMC article. Review.
-
Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.Value Health. 2021 Jan;24(1):32-40. doi: 10.1016/j.jval.2020.05.022. Epub 2020 Nov 5. Value Health. 2021. PMID: 33431151
-
Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.Value Health. 2021 Jan;24(1):19-31. doi: 10.1016/j.jval.2020.10.011. Epub 2020 Dec 11. Value Health. 2021. PMID: 33431149
-
Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.BMC Med. 2020 Jan 14;18(1):11. doi: 10.1186/s12916-019-1471-x. BMC Med. 2020. PMID: 31931789 Free PMC article.
-
Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations.Drugs. 2012 Jan 1;72(1):35-48. doi: 10.2165/11597310-000000000-00000. Drugs. 2012. PMID: 22191794 Review.
Cited by
-
The impact of influenza infection on young children, their family and the health care system.Influenza Other Respir Viruses. 2019 Jan;13(1):18-27. doi: 10.1111/irv.12604. Epub 2018 Sep 11. Influenza Other Respir Viruses. 2019. PMID: 30137663 Free PMC article.
-
Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Epub 2013 Jan 28. Hum Vaccin Immunother. 2013. PMID: 23357859 Free PMC article. Review.
-
Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges.Pharmacoeconomics. 2016 Aug;34(8):723-31. doi: 10.1007/s40273-016-0393-0. Pharmacoeconomics. 2016. PMID: 26914091
-
Influenza vaccination in the COVID-19 era.Early Hum Dev. 2020 Sep;148:105116. doi: 10.1016/j.earlhumdev.2020.105116. Epub 2020 Jun 18. Early Hum Dev. 2020. PMID: 32604011 Free PMC article.
-
Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review.Vaccines (Basel). 2021 Feb 2;9(2):111. doi: 10.3390/vaccines9020111. Vaccines (Basel). 2021. PMID: 33540633 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical